ImageCoreLab

Home
India
Bangalore
ImageCoreLab

Call Directions Website Contact the practice

ICL is committed to assist Sponsor companies and CRO’s with their imaging requirements as they desire

Exploring a need in the clinical trial space for an integrated image management company that has the resources and technology to offer optimal and cost efficient solutions to pharmaceutical, biotechnology, medical device companies and other organizations such as CROs, engaged in global imaging clinical studies.

04/11/2026

Image Core Lab ensures every box on your site qualification checklist is marked for consistent imaging across all clinical trial sites.

️✅ Imaging Capability Assessments to evaluate and standardize site readiness
✅ Imaging Staff Training to ensure image quality meets trial requirements
✅ Proactive Support to maintain compliance throughout the trial lifecycle

Our expertise ensures every site qualifies for a consistent and successful imaging interpretation.

👉 Visit https://imagecorelab.com/core-imaging-services/ to partner with us!

02/11/2026

AI can help flag critical findings. But developing an AI or SaMD solution that performs reliably in clinical practice takes more than an algorithm.

Real-world imaging brings variability across scanners, protocols, patient populations, and clinical interpretation. That is where robust imaging expertise and evidence become essential.

Image Core Lab supports Radiology AI and SaMD development across:
• Expert annotation and segmentation
• Ground truth development
• Multi-reader multi-case (MRMC) study design
• Technical validation

From development to validation, ICL brings board-certified radiologists and structured imaging workflows to help AI and SaMD teams build clinically relevant, defensible evidence.

Developing an imaging AI or SaMD solution? Bring clinical imaging expertise into your development process.

👉 Explore ICL’s Radiology AI & SaMD capabilities: https://imagecorelab.com/clinical-services-in-radiology-ai-and-samd/

29/10/2026

World Stroke Day | Imaging Matters in Stroke Research

How is treatment response assessed in stroke clinical trials?

Imaging helps researchers evaluate infarct volume, lesion evolution and safety findings across study timepoints.

At Image Core Lab (ICL), centralized imaging interpretation, standardized assessments and quality control support consistency across clinical trials.

This World Stroke Day, we recognize the role of reliable imaging in advancing stroke research.

Explore our core imaging services:
https://imagecorelab.com/core-imaging-services/

27/10/2026

Renal cancer trials demand precise imaging assessment to track tumour response and disease progression against protocol-defined endpoints.

Image Core Lab brings specialized oncology imaging expertise to clinical trials, supporting consistent, protocol-driven assessment across study sites.

Our capabilities include:

📌 Response Assessment: RECIST 1.1 and other applicable response criteria, based on the study protocol.
📌 Centralized Reads: Standardized lesion assessment and disease progression tracking across multicentre trials.
📌 Imaging Quality Oversight: Structured quality checks to help manage inter-site variability.
📌 Quantitative Imaging: Tumour burden evaluation aligned with study-defined endpoints.

For sponsors and CROs, our focus is on reliable imaging assessments that support the evaluation of oncology trial endpoints.

Explore our oncology clinical trial imaging expertise:
https://imagecorelab.com/oncology-clinical-trial-imaging-expertise/

26/10/2026

Diagnostic accuracy and workflow efficiency are foundational to effective emergency neuroimaging.

A meta-analysis in Brain and Spine by Dr. Arjun Kalyanpur et al. evaluates the diagnostic performance and clinical applications of artificial intelligence for detecting intracranial hemorrhage (ICH) on CT scans.

Drawing on evidence from 29 research algorithms and 16 commercial AI system implementations, the analysis confirms high diagnostic accuracy for ICH detection, with commercial systems demonstrating stronger specificity.

While detection performance varies across hemorrhage subtypes, real-world deployments show measurable clinical impact, including faster treatment decisions and earlier escalation of critical cases.

The findings also highlight key priorities for the field, including prospective validation and targeted algorithm development across challenging ICH subtypes.

At Image Core Lab, we support radiology AI and SaMD development through expert annotation, ground truthing, and technical validation, with a focus on real-world clinical performance.

Read the full publication here: https://doi.org/10.1016/j.bas.2025.105866

To read more articles and obtain additional insights on clinical trial imaging, visit: https://imagecorelab.com/publications/

Dr. Arjun Kalyanpur, Founder and Chief Radiologist, Image Core Lab

25/10/2026

Client Spotlight | GuideAI Health x Image Core Lab

Strong radiology AI starts with stronger imaging foundations.
That’s precisely what we delivered with GuideAI Health and Dr. Raj Shah, CEO, shares why our collaboration mattered.

Radiology AI and SaMD solutions often falter not because of algorithms, but because clinical validation, structured annotation, and real-world robustness are overlooked, especially in complex modalities like CT angiography and vascular imaging.

𝐈𝐦𝐚𝐠𝐞 𝐂𝐨𝐫𝐞 𝐋𝐚𝐛 partner with AI and medical device teams to deliver:

🔹 Radiologist-led annotation & lesion segmentation
🔹 Gold-standard ground truth & MRMC study design
🔹 Technical performance validation across diverse imaging environments

Whether you’re building AI for stenosis detection in PAD, CTA-based morphology classification, or multi-modality radiology workflows, partnering with a clinical imaging core lab strengthens model reliability and accelerates adoption.

📽️ Watch the full testimonial to hear Dr. Shah’s perspective on how rigor in annotation and validation shaped their product journey.

👉 Learn how our clinical services support Radiology AI & SaMD development:
🔗 https://imagecorelab.com/clinical-services-in-radiology-ai-and-samd/

24/10/2026

From early-phase research to Phase III and IV studies, imaging helps sponsors evaluate treatment effects, assess efficacy, and generate evidence against clinical endpoints.

Image Core Lab has completed 35+ clinical trial projects, bringing imaging expertise across all trial phases.

Our capabilities include:

✓ Imaging charter development and protocol review
✓ Site qualification and training
✓ Imaging standardization and centralized interpretation

Support your trial with imaging expertise across every phase of clinical development.

Explore our core imaging services:
https://imagecorelab.com/core-imaging-services/

23/10/2026

Inconsistent imaging data. Unreliable performance assessments. Challenges in clinical deployment.

Radiology AI depends on more than model architecture. Annotation quality, reliable ground truth, and clinically informed validation all influence how model performance is assessed.

With 14+ years of imaging expertise and 75+ AI projects, Image Core Lab supports radiology AI and SaMD developers through:

✓ Expert annotation and segmentation
✓ Ground truth development
✓ Validation and MRMC study design

From plaque segmentation and orthopaedic landmark analysis to blood clot detection and lesion-level annotation, ICL brings radiological expertise to AI development and validation.

Strengthen the imaging evidence behind your AI.

Explore our AI and SaMD services:
https://imagecorelab.com/clinical-services-in-radiology-ai-and-samd/

22/10/2026

Glioma remains one of the most aggressive and common primary brain tumors, making imaging assessments critical in neuro-oncology trials.

Sponsors rely on experienced centralized core labs to reduce inter-reader variability and support consistent, reliable tumor response assessments across multi-site studies.

Image Core Lab brings specialized neuro-oncology imaging expertise to glioma and brain tumor studies, using RANO criteria, the globally accepted standard for evaluating tumor response in neuro-oncology.

Our approach combines:

🔹 Expert centralized reads by experienced neuroradiology teams
🔹 Standardized response assessment aligned with RANO
🔹 Reliable imaging assessments to support clinical trial endpoints

For sponsors seeking a trusted partner for centralized reads in neuro-oncology trials, Image Core Lab brings the expertise and consistency these studies demand.

Partner with Image Core Lab: https://imagecorelab.com/therapeutic-expertise/

20/10/2026

Artificial intelligence is advancing thoracic imaging by supporting the detection, interpretation, and assessment of diseases affecting the lungs and vascular system.

As the burden of respiratory and pulmonary vascular conditions, including pneumonia and pulmonary embolism, continues to challenge healthcare systems, AI is helping to:

✅ Improve the detection of critical thoracic abnormalities
✅ Support diagnostic accuracy and consistency
✅ Streamline image interpretation and inform clinical decision-making

These developments are explored in the review by Dr. Arjun Kalyanpur and Dr. Neetika Mathur, published in Academia Medicine.

📖 Read the full article or listen to the accompanying AI podcast: https://doi.org/10.20935/AcadMed7509

Explore more of our research and publications: https://imagecorelab.com/publications/

Dr. Arjun Kalyanpur is Founder and Chief Radiologist of Image Core Lab

Address

Plot # 7G, Opp Graphite India Whitefield
Bangalore
560048

Telephone

+918049261100

Website

http://www.imagecorelab.com/

Alerts

Be the first to know and let us send you an email when ImageCoreLab posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.